Impurities in drugs directly impact the safety, efficacy, and stability of the drug. Impurity research is a critical component of drug development and quality control, not only pivotal for the successful approval of drug marketing applications but also fundamental to safeguarding patient medication safety. Protheragen Impurity is dedicated to providing a range of drug impurity reference standards with the highest purity and most complete data, along with related services, for global new drug development, generic drug development, quality control, and regulatory submissions.
Our mission is to assist pharmaceutical companies in accurately identifying, quantifying, and controlling impurities in drugs, reducing drug development risks, accelerating the drug approval process, and ultimately providing safer and more effective treatments for patients worldwide.


We are proud that our products have been instrumental in helping numerous pharmaceutical companies overcome impurity-related challenges in development and manufacturing, and ultimately delivering safer and more effective drugs to patients.
Lisa R., Purchasing Director
Dr. Alex W., Drug Development Scientist
Sarah T., Quality Assurance Manager
Mark R., Formulation Scientist
Daniel L., Project Manager